Related Articles
Extrahepatic manifestations and insulin resistance in an HCV hyperendemic area
Effect of occult hepatitis B virus infection on the early-onset of hepatocellular carcinoma in patients with hepatitis C virus infection
Absence of differences in the recurrence rates of hepatitis C virus‑associated hepatocellular carcinoma between direct‑acting antivirals and interferon‑based treatments: A multicenter study
Adjuvant interferon for early or late recurrence of hepatocellular carcinoma and mortality from hepatocellular carcinoma following curative treatment: A meta‑analysis with comparison of different types of hepatitis
Serum microRNA‑125a‑5p as a potential biomarker of HCV‑associated hepatocellular carcinoma